|
|
|
|
|
by SomaticPirate
60 days ago
|
|
I agree with you but Ozempic is a bad example here. Part of the reason it is so valuable is that patients usually must take it for the rest of their lives. Its actually the perfect example of “evil” pharma since patients slmost akways regain the weight if they stop taking it. This leads to dependence or people searching for grey market sources. An example of “good” pharma would be Hepatitis C. We can now cure that. Although, pharma is charging the lifetime equivalent in order to do that (a treatment can run over $100k and insurance balks at covering it) So pharma will absolutely develop a cure if they can. They however will still charge you as if you had to take a dose for the rest of your life. |
|